Saturday, July 17, 2021
The Hemp CBD Times. Every minute hemp cbd industry news.

Category: Draft Guidance


FDA’s Draft Guidance for Clinical Research Regarding Cannabis and Cannabis Derivatives Takes a Firm Stance on the 0.3% THC Level

 By Agustin Rodriguez and Dascher Pasco  On Tuesday, July 21, 2020, the U.S. Food and Drug Administration (FDA) issued “Cannabis…

By hempcbdtimes , in clinical research Draft Guidance Drug Enforcement Agency (DEA) Hemp Policy & Legal U.S. Food and Drug Administration (FDA) , at August 25, 2020